Celprogen Introduces Stem Cells In Syringes For In Vivo Applications

Main Category: Stem Cell Research
Article Date: 19 Sep 2008 - 7:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

5 (1 votes)

Healthcare Prof:not yet rated


Celprogen Inc., a Global leader in the Stem Cell Research and Therapeutics industry for development of stem cell technologies in regenerative medicine, announced that they have successfully validated shipment of embryonic and adult stem cells at room temperature within United States research facilities for in vivo applications. These Stems including progenitor cells were derived from the following species mouse, rat and human.

Celprogen's stem cells and progenitor cells in the syringes are available for basic science research and drug discovery. The stem cells validated in syringe shipment are as follows: Hepatocytes, Neuronal, Pancreatic, Gastric, Cardiomyocytes, Colon, Lung and Keratinocytes. These stem cells in their syringes are able to maintain their stem-ness and are able to engraft at their organ specific sites once injected within 3 to 5 days from the date shipped. Celprogen has successfully shipped stem cells globally at room temperature in Tissue culture flasks to Asia, Europe and United Kingdom.

Celprogen provides Stem Cell Tissue culture system which includes cells, pre-coated flasks with extracellular matrix and Medium for growth and proliferation of these cells. The stem cell culture system includes stem cell differentiation, expansion and maintaining stem cells in their undifferentiated stage.

About Celprogen Inc.

Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing proprietary portfolio of unique cancer therapeutics products and life science research tools that includes stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in San Pedro, California, Celprogen is committed to the research, development, and manufacture of quality Stem Cell products to serve our global community.

Celprogen Inc.

Article adapted by Medical News Today from original press release.
Visit our stem cell research section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Celprogen Inc.. "Celprogen Introduces Stem Cells In Syringes For In Vivo Applications." Medical News Today. MediLexicon, Intl., 19 Sep. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/122187.php>

APA
Celprogen Inc.. (2008, September 19). "Celprogen Introduces Stem Cells In Syringes For In Vivo Applications." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/122187.php.

Please note: If no author information is provided, the source is cited instead.


Stem Cell Research

What are Stem Cells?

Stem cells are a class of undifferentiated cells that are able to differentiate into specialized cell types. Commonly, stem cells come from two main sources: embryonic stem cells and adult stem cells Read more...

Most Popular Articles



Follow Our Stem Cell Research News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Stem Cell Research Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »